# Phosphate in Blood Pressure Regulation

> **NCT02822131** · NA · COMPLETED · sponsor: **University of Zurich** · enrollment: 10 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** sodium phosphate
- **DRUG:** sevelamer, sodium bicarbonate, sodium chloride

## Key facts

- **NCT ID:** NCT02822131
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822131, "Phosphate in Blood Pressure Regulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02822131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*